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Dear Errol
I enclose a manuscript entitled “Transcriptional changes in trichothiodystrophy cells”
that we would like to be considered for publication in DNAR. This paper reports on a 
very careful study that we have carried out, using micro-arrays, to look for specific 
transcriptional differences between TTD fibroblasts and XP-D or normal fibroblasts, 
both in unirradiated and irradiated cells. We were not able to detect any differences 
that could be attributed to a TTD-specific genotype. En route our study highlights a 
number of potential pitfalls that need to be avoided when using such an approach. In 
particular using a single defective cell line and its corrected derivative might generate 
data that can be easily misinterpreted.
We hope that the results in this paper will be of interest to readers of DNAR.
Best regards.
Alan
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2Abstract
Mutations in three of the genes encoding the XPB, XPD and TTDA components of 
transcription factor TFIIH can result in the clinical phenotype of trichothiodystrophy 
(TTD). Different mutations in XPB and XPD can instead cause xeroderma 
pigmentosum (XP). The completely different features of these disorders have been 
attributed to TTD being a transcription syndrome. In order to detect transcriptional 
differences between TTD and XP cells from the XP-D complementation group, we 
have compared gene expression profiles in cultured fibroblasts from normal, XP and 
TTD donors. Although we detected transcriptional differences between individual cell 
strains, using an algorithm of moderate stringency, we did not identify any genes
whose expression was reproducibly different in proliferating fibroblasts from each 
type of donor. Following UV-irradiation, many genes were up- and down-regulated in 
all three cell types. The micro-array analysis indicated some apparent differences 
between the different donor types, but on more detailed inspection, these turned out 
to be false positives. We conclude that there are minimal differences in gene 
expression in proliferating fibroblasts from TTD, XP-D and normal donors.
31. Introduction
Defects in any of seven different genes (XPA to G) involved in nucleotide excision 
repair (NER) can result in the genetic disorder xeroderma pigmentosum (XP), the 
principal features of which are extreme sensitivity of the skin to sunlight-induced 
pigmentation changes and skin cancers. The incidence of skin cancer is about 2000-
fold greater for XP patients compared to the normal population [1], and is entirely 
caused by exposure to sunlight. In addition, about one third of XP patients suffer from 
progressive neurological degeneration [2]. Cells isolated from XP patients are 
hypersensitive to UV-irradiation, which can be reversed by complementation with a 
wild type copy of the corresponding NER gene. 
Mutations in the XPD gene can also result in several other clinical phenotypes, the 
most common of which is trichothiodystrophy (TTD) [3,4]. TTD shows none of the 
sunlight-induced skin pigmentation changes characteristic of XP, but is a multi-
system disorder, the hallmark of which is sulphur-deficient brittle hair. This is caused 
by a reduced expression of cysteine-rich matrix proteins in the late stage of
keratinocyte differentiation in the hair shaft [5]. Other symptoms include mental 
retardation, unusual facies, ichthyotic skin, and reduced stature. About half of all TTD 
patients are photosensitive with either moderate or severe cell sensitivity to UV [6].
A clue to understanding how defects in the same gene can result in such different 
clinical features came with the discovery that the XPD helicase was a component of 
the transcription factor TFIIH, which has dual roles in NER and transcription [7]. In 
NER, TFIIH opens up the site around the lesion permitting excision of the damaged 
base, whereas in transcription TFIIH opens up the DNA at the promoter site enabling 
access to the transcription machinery [8]. Both processes require helicase activity, 
but this is provided by the XPD protein only in the case of NER [9]. For transcription 
4initiation, the XPD helicase does not have to be active and XPD seems only to play a 
structural role in maintaining the stability of the TFIIH complex. 
TFIIH consists of ten subunits, five of which (XPB, p62, p52, p44 and p34) make up 
the core complex [10-13]. The helicase activity of XPB, required for transcription, 
functions in the opposite direction to that of XPD (3’ to 5’ for XPB and 5’ to 3’ for XPD)
[14]. XPD is associated both with the core complex via binding to p44 and with the 
CAK (cyclin activating kinase) complex (cyclin H, cdk7 and MAT1), bridging both sub-
complexes together. The interaction with p44 stimulates the helicase activity of XPD 
by 10-fold [14]. The tenth subunit, TTD-A / p8, was identified recently and binds both 
p52 and XPD [12,13]. Mutations in XPB and TTD-A can also result in TTD [4].
Features of XP are thought to result from defective NER, whereas TTD has been 
considered a transcription syndrome [15]. Consistent with this hypothesis, it has been 
found that, with one or two exceptions, mutations generating the XP and TTD 
phenotypes are located at different, mutually exclusive sites in the XPD gene [16]. 
Even though each mutated site is only found in either XP or TTD patients, there are 
no disease specific domains and mutations causing changes in adjacent amino acids 
can result in different disease phenotypes. 
It has been hypothesised that the disease phenotype of TTD is caused by defects in 
both basal [17] and activated transcription [18-21]. Transcriptional activation by 
different nuclear hormone receptors is reduced in TTD cells, for example the R722W 
mutation in mice results in the deregulation of thyroid hormone targets in the brain 
[21]. Although the transcription syndrome hypothesis for TTD is attractive and has 
gained wide acceptance, there is to date little direct or detailed evidence to indicate 
the precise nature of this transcriptional deficiency, nor has any satisfactory 
explanation been provided as to why, despite similar NER deficiencies in XP and 
5some TTD cell lines, TTD patients show none of the cutaneous abnormalities found 
in XP. To try and gain further insight into possible transcription anomalies in TTD, we 
have used expression profiling on microarrays to look for transcriptional differences 
between TTD, XP and normal primary fibroblasts, either without treatment or 
following exposure to UV-C-irradiation.
62. Materials and Methods
2.1. Cell strains 
Cultured primary skin fibroblasts were used in all our experiments (Table 1). All cell 
strains were maintained in MEM supplemented with 15% fetal calf serum at 37°C. 
Details of the mutation analysis of these strains have been described previously 
[16,22,23]. 
2.2. RNA synthesis
The RNA synthesis levels after UV-C-irradiation were determined as described in 
[24].
2.3. UV-irradiation and RNA extraction
48 h after plating, when cells were semi-confluent, they were UV-C-irradiated with the 
doses described in Table 1. Total RNA was extracted 12 h after irradiation using the 
RNeasy kit (Qiagen). To ensure that a temperature shift to room temperature before 
or during cell lysis did not affect changes in gene expression, the cells were lysed at 
37°C. The remainder of the extraction procedure was performed at room temperature 
following the manufacturer’s protocol. A DNase treatment was included in the 
purification. 
2.4. Preparation of cRNA samples and hybridisation to Affymetrix chips
The total RNA samples were converted to double stranded (ds) cDNA using the 
‘cDNA Synthesis System’ (Roche) following the standard protocol with oligo[(dT)24 T7 
promoter]65 primer. 5μg of total RNA was transcribed per sample. The ds cDNA was 
cleaned-up using the ‘Affy clean-up’ kit (Qiagen) following the manufacturer’s 
instructions. All of the ds cDNA obtained was then amplified and biotinylated using 
the ‘GeneChip Expression 3’-Amplification Reagents for IVT Labeling’ kit (Affymetrix) 
following the standard protocol. The ‘Affy clean-up’ kit was used again to purify the 
7biotinylated cRNA. The quality of the starting total RNA and biotinylated cRNA was 
determined using the 2100 Bioanalyser (Agilent Technologies). 
2.5. Analysis of gene expression with and without UV treatment
The biotinylated cRNA samples were fragmented and hybridized to Affymetrix HG 
U133 Plus 2.0 arrays following the standard protocol. These whole genome arrays 
contain more than 54,000 probesets, allowing analysis of the expression level of 
>38,500 human transcripts. The data obtained were analysed using Genespring 6.0, 
and also by LIMMA in the R environment for statistical computing. First, the data 
were normalized using the GCRMA model. This method performs within-chip and 
between-chip normalization in one step [25]. t-tests were then performed on the 
normalized data employing the False Discovery rate (Benjamini-Hochberg) multiple-
testing correction [26].
LIMMA uses Bayesian statistics to compute the probability of a gene being 
differentially expressed in any defined contrast, for example TTD compared to normal 
[27]. This statistical test measures the probability of an outcome, for example a gene 
being differentially expressed, calculated from a ratio of the probabilities of the 
experimental outcome and the prior assumption of the experimental outcome. A log 
odds value of zero corresponds to a 50-50 chance that a gene is differentially
expressed. Hence, the higher the log odds, the higher the probability that a gene is 
not a false positive. A log odds ratio around 5 was used as a cut off to identify genes 
which are most likely to be differentially expressed. 
82.6. GSTT1 gene analysis by PCR amplification
A 480-bp fragment of the GSTT1 gene (primers described in [28]) was amplified in a 
multiplex PCR with a 704-bp control fragment (primer set DJg5/g6 [29]) from 
genomic DNA. The PCR products were analysed on a 1% agarose gel. 
2.7. Identification of enriched biological themes
The software application EASE identifies gene categories containing an over-
representatively high number of differentially expressed genes among the gene lists 
obtained from the LIMMA analysis. EASE uses the systems of Gene Ontology (GO) 
as categorization system and a variation of the one-tailed Fisher exact probability to 
measure over-representation referred to as EASE score. Gene ontology groups with 
an EASE score of less than 0.05 were considered to be statistically significant. If a 
number of associated GO groups were identified from the same gene list the group 
highest in the hierarchy without being too general was used.  
2.8. Quantitative real-time PCR
All kits used for this analysis were obtained from Qiagen and standard protocols were 
followed unless otherwise stated. Real-time PCR assays were run on the Stratagene 
Mx3005P instrument. Samples for analysis by qPCR were prepared as follows. The 
UV treatment and RNA purification was performed as described above. 2μg of total 
RNA was converted to single stranded cDNA using the ‘QuantiTect Reverse 
Transcription’ kit using the RT primer mix provided, which contains a blend of oligo-
dT and random primers. Real-time PCR reactions were performed using the 
‘QuantiTect Primer Assays’ and the ‘QuantiTect SYBR Green PCR’ kit. First, 
standard curves were set up for each primer set. Three housekeeping genes were 
assayed to find the best gene to use as a normaliser for the comparative 
9quantification. TATA-binding protein (TBP) was chosen as the most suitable gene for 
normalisation as its expression level was the most similar to all the genes assayed 
and little variation was observed among the Ct values obtained from the UV 
treatment samples. For each gene of interest every sample was assayed in duplicate 
and the log2(fold change) was calculated comparing the average of the treated with 
the untreated values for each cell strain. 
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3. Results
The goal of our study was to determine if specific genes were expressed at different 
levels in TTD cells mutated in the XPD gene compared to XP cells mutated in the 
same gene and to normal cells. By this means we hoped firstly to gain insights into 
any transcriptional deficiencies in TTD cells and also to understand why TTD patients 
do not get skin cancer whereas XP patients do. 
3.1. Comparison of gene expression in corrected isogenic cell lines
Our first approach was to use an isogenic system of TTD primary fibroblasts 
transduced with a retroviral vector expressing either XPD cDNA to correct the defect 
or the E. coli lacZ gene as a negative control. In triplicate experiments using 
TTD1BEL as a recipient, we found 36 genes whose expression was changed 
reproducibly more than 2-fold (p < 0.05) in the corrected versus uncorrected cells. 
Encouraged by these findings, we carried out similar experiments using another TTD 
cell strain, TTD7BR, as well as the normal cell strains 1BR and XP1BR XP-D cells. 
We found about 50 genes whose regulation was changed (p < 0.05) on transduction 
of the TTD7BR cells but not in the other two cell strains. However, there was no 
overlap between the genes whose expression was changed by correction of 
TTD1BEL and of TTD7BR cells. Thus, although statistical analysis of the data 
showed that the expression changes observed for each cell line were significant and 
consistent, the changes that we observed appeared to be cell line-specific rather 
than genotype-specific.
3.2. Comparison of gene expression in untreated cultured fibroblasts
Since we were interested in identifying genes that might be fundamental to the TTD 
phenotype, we next adopted a different approach and compared the transcriptional 
profiles of three normal, three XP-D and three TTD fibroblast strains (Table 1) to look 
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for differences that were found in all three TTD strains compared with the three XP-D 
and the three normal cell strains. Data were analysed using the LIMMA package.
When we compared the transcription profiles for 54,673 probe sets of untreated cells 
in all three groups, we found only one gene, Glutathione S-transferase Theta (GSTT1) 
that appeared to be differentially expressed (down-regulated) in all TTD strains 
compared to normal and XP-D cells. GSTT1, however, is absent from 38% of the 
population [30]. PCR screening of the genome of the three strains used for the 
microarray experiment showed that the GSTT1 gene was indeed absent (Fig. 1, 
lanes 5 - 7). However, analysis of an additional four TTD cell strains mutated in the 
XPD gene showed the presence of GSTT1 in three of them (Fig. 1, lanes 1 - 4), thus 
discounting a correlation between the GSTT1- genotype and the TTD phenotype.
3.3. Comparison of UV-induced changes in gene expression
In subsequent experiments we compared the transcriptional changes in TTD, XP-D 
and normal cells irradiated with a UV-C dose that causes a reduction to 
approximately fifty percent of normal RNA synthesis (Fig. 2). The question we sought 
to address was whether there were genes up- or down-regulated by UV in all three 
TTD strains that were not altered in either group of XP-D or normal cells, or vice 
versa. Fig. 2 shows the responses of RNA synthesis to UV-irradiation in the cell 
strains used in the microarray experiments. Approximately 50% inhibition was 
achieved with 4 Jm-2 for all the XP-D strains, as well as for TTD1BEL and TTD9VI, 8 
Jm-2 for TTD7BR and 12 Jm-2 for the normal cells. These doses were used in the 
microarray experiments (Table 1). We found that a total of 5283 probe-sets were 
differentially expressed after UV damage in one or other cell type (Tables 2 and S1, 
Fig. 4). 1172 genes were induced after UV in TTD cells compared to 1294 in XP-D 
and 1404 in normal cells, and 1488 genes were down-regulated in TTD cells 
compared to 2373 in XP-D and 1155 in normal cells. 
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To obtain a better understanding of the biological and molecular processes and 
pathways affected we analysed the lists of differentially expressed genes using 
GenMAPP (Gene MicroArray Pathway Profiler) and EASE (Expression Analysis 
Systematic Explorer). Both these software packages are used to identify groups of 
biologically related genes showing a large number of gene-expression changes 
[31,32]. Both programs classify large gene lists into functionally related gene groups 
allowing the analysis of gene expression data in the context of biological pathways. 
Using both software packages we identified similar functional groups and biological 
processes. 
Fig. 3 shows the biological themes identified with EASE. The bars represent the 
percentage of genes in this gene list of all differentially expressed genes of a specific 
contrast. For example, 56 of a total number of 1172 genes up-regulated in TTD cells 
after UV were in the gene ontology group ‘RNA metabolism / processing’. In general, 
the biological processes identified from the genes differentially expressed in TTD, 
XP-D and normal cells were very similar. In addition, the number of genes found in 
the different Gene Ontology (GO) groups as a fraction of the genes differentially 
expressed after UV was similar for each cell type. This is especially the case for 
genes that were repressed after UV, where the differences observed were minimal 
(Fig. 3B). The only category, which differed, was ‘transcription’ where a slightly larger 
proportion of genes were down-regulated in XP-D cells (10.5% compared to 8.9% in 
TTD and 7.4% in normal cells). The up-regulated biological pathways differed more 
significantly (Fig. 3A). Specifically, in four categories more genes were induced in 
normal cells compared to TTD and XP-D cells. For example, 3.35% of genes in the 
protein targeting and transport group were induced in normal cells compared to 
1.28% in TTD and 1.24% in XP-D cells. A similar pattern was observed for the ‘DNA 
metabolism/replication’ (4.91% in normal, 3.09% in XP-D and 2.9% in TTD cells), 
‘protein biosynthesis / folding’ (6.91% in normal, 4.4% in XP-D and 4.61% in TTD 
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cells), and ‘RNA metabolism / processing’ (7.19% in normal, 4.33% in XP-D and 
4.78% in TTD cells) GO gene groups. In addition, normal cells induced a larger no of 
cell cycle genes (5.3%) compared to TTD (4.1%) and XP-D (3.63%) cells. 
The gene lists were compared to one another to identify any overlapping genes and 
genes uniquely changed in one of the contrasts (Fig. 4A and B).  A large number of 
genes were differentially expressed in all three cell types after UV-irradiation; 630 
genes were down-regulated and 515 genes up-regulated. This analysis also 
identified genes whose expression appeared to change after UV only in one specific 
cell type, for example TTD cells (Fig. 4A and B), where 225 probe sets were up- and 
156 probe sets down-regulated only in this cell type. In addition we identified genes 
whose expression appeared to change in normal and XP-D but not in TTD cells. We 
analysed the raw data for all nine cell strains in more detail for all of these genes. It 
became evident that most of the apparent differences were false positives, due to 
either (1) very low gene expression levels such that the data were unreliable, or (2) 
increased scatter of the data from cells with one phenotype so that UV-induced 
changes with this phenotype did not reach statistical significance, whereas they were 
significant with the other phenotypes. Careful analysis of all the individual expression 
values enabled us to eliminate as false positives all but 11 of the probe-sets as 
candidates for differential expression between the different phenotypes. Nine of 
these eleven genes were chosen for further analysis by qPCR (Fig. S1). For eight of 
these, qPCR did not confirm the differences suggested by the microarrays. Only one 
of the genes analysed, HOXC4, was confirmed to be down-regulated after UV 
specifically in TTD cells (Fig. S2). We therefore analysed three additional TTD cell 
strains with different XPD mutations and the UV-induced change in HOXC4 gene 
expression was measured by qPCR. However, the specific repression of this gene 
after UV-irradiation could not be confirmed in these cells (data not shown). 
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4. Discussion
We have used two different approaches to look for transcriptional differences 
between TTD cells on the one hand and XP and normal cells on the other hand. The 
first approach entailed comparing the transcriptional profiles of cells in which the 
phenotype has been corrected by introduction of the wild-type XPD gene. A similar 
approach was used by Costa et al. with XP-B cells [33]. They used a cell line from a 
patient with the combined features of XP and CS as recipient for XPB cDNA 
containing either the same mutation as found in the recipient cell or a mutation found 
in a TTD patient. This approach has the advantage that comparisons are made 
between isogenic cells, and both we and Costa et al. were able to identify differences 
in expression of several genes between the test and control samples. In our study 
however, we found that the changes in gene expression on correction of the 
phenotype differed between cell lines. In the study of Costa et al. only one recipient 
cell line was used, so we do not know if the changes that they observed would be 
confirmed using other recipient cells. In our experiments we found that the XPD gene 
was over-expressed up to 30-fold in the transduced cells, and this in itself could 
result in some distortion of the expression profiles. Selzer et al. also employed this
approach to investigate the role of the CSB protein in basal transcription [34]. They 
used the Atlas human arrays (746 genes) and NIA cDNA arrays (15000 ESTs) to 
look for differential gene expression between a CS-B fibroblast line stably transfected 
either with functional CSB or empty vector. In this study however, the authors did not 
find any significant differences in the expression of the genes assayed between the 
two isogenic cell lines. Our results emphasize the importance of using several 
different cell lines from a particular disorder in this type of analysis.
Despite the attraction of the isogenic system, we decided that it was important to 
compare cohorts of unrelated TTD, XP and normal cells and to look for common 
differences between the cohorts. It has been suggested that the developmental 
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defects resulting in the features of TTD are caused by deficiencies in transcription 
[15]. When we analysed gene expression profiles in untreated TTD, XP-D and 
normal proliferating fibroblasts we could not identify any phenotype-specific 
differences. In a recent study, Dorioli et al found a deficiency in TTD fibroblasts in 
upregulation of the COL6A1 gene when the cells entered confluence (personal 
communication). This difference in expression was, as in our study, not seen in 
proliferating cells. As the symptoms of TTD appear to be mainly caused by 
developmental defects, it is possible that significant differences in transcription only 
occur and/or can be measured in differentiating cells (as has been suggested by de 
Boer et al. [35]) and not in proliferating skin fibroblasts. Interestingly, transcriptional 
differences in differentiated tissue were observed in the TTD mouse (XPDR722W) [17]
and in erythrocytes from TTD patients [22]. The phenotype of the TTD mouse mimics 
the human condition extremely well, including the skin conditions observed in 
patients. The authors analysed the transcription levels of the SPRR2 gene, a 
member of a family of small proline-rich proteins, which is expressed late in terminal 
differentiation of interfollicular keratinocytes [36]. They found that transcript levels 
were reduced by 2.5- to 3-fold in the dorsal skin of TTD mice compared to wt [17]. 
Many genes are known to be up- or down-regulated following exposure to DNA 
damaging agents and there are several reports on expression profile changes 
following UV-irradiation of human cells [33,37-40]. Likewise we observed many 
genes clearly up- or down-regulated following UV-C-irradiation of human fibroblasts. 
Several categories, DNA metabolism, replication and repair, RNA metabolism and 
processing, protein biosynthesis, folding and targeting, cell cycle, chromosome 
organisation and a number of other pathways contained both genes that were up-
and down-regulated. Biological processes that seemed to only contain repressed 
genes include phosphate metabolism, proteolysis and peptidolysis, signal 
transduction, and telomere maintenance. GO groups specifically up-regulated 
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included nitrogen metabolism, nucleotide metabolism, and ribosome biogenesis and 
assembly. Similar GO groups affected by UV-irradiation were identified in other 
studies. Koch-Paiz et al. for example also found genes in DNA repair, cell cycle 
regulation, transcription, protein modification and chromatin related affected by UV-C 
[38].  Microarray analysis of rat cardiac fibroblasts identified similar groups as targets 
after UV [40]. They found up-regulation of a number of processes involved in 
regulation of the cell cycle, protein metabolism, transcription, translation and others. 
They also identified groups, which seemed to be unique to the cell system they were 
using like cholesterol biosynthesis and lipid metabolism. 
Using the second approach, we identified a number of genes that appeared to be 
differentially expressed after UV only in TTD, but not in XP-D or normal cells. 
However, more careful analysis of the data and further tests using quantitative RT-
PCR showed that these were all false positives. In conclusion, using the two 
experimental systems described above we were not able to identify, in proliferating 
fibroblasts, any transcriptional differences specific for TTD cells that could explain the 
symptoms of the disease or the lack of UV-induced skin cancer in TTD patients. Thus 
despite the clear evidence for a 40-60% decrease in the in vitro transcriptional 
activity of TFIIH containing TTD-specific mutant XPD protein [9] and the 
demonstration that TFIIH levels in TTD fibroblasts are only 40-60% of those in 
normal and XP fibroblasts [41], remarkably these deficiencies appear to have a 
minimal effect on the gene expression profile in untreated or UV-irradiated TTD 
fibroblasts. This further reinforces the hypothesis of [17] that the transcriptional 
deficiency associated with TTD-specific mutations is only manifest in specialised 
tissues dependent on high levels of active TFIIH.
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Table 1 - Primary fibroblast cultures and treatments
TTD XP wt
Cell linea UV treatment Cell line UV treatment Cell line UV treatment
TTD1BEL 
(R722W)
0, 4 J/m2
XP1DU 
(R683W)
0, 4 J/m2 1BR 0, 12 J/m2
TTD7BR 
(R487G)
0, 8 J/m2
XP1BR 
(R683W)
0, 4 J/m2 48BR 0, 12 J/m2
TTD9VI 
(R112H)
0, 4 J/m2
XP30BR 
(R683Q)
0, 4 J/m2 245BR 0, 12 J/m2
aFor each cell line the causative mutation is indicated
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Table 2 - Genes differentially expressed after UV damage
Number of genes meeting significance criterion 
Benjamini-Hochberg p<0.05 TTD4-TTD0 XP4-XP0 WT12-WT0
Down-regulated 1488 2373 1155
No change 52015 51008 52116
Up-regulated 1172 1294 1404
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Fig. 1 - GSTT1 analysis in TTD cell strains. 
The presence of the GSTT1 gene was analysed by PCR in the three TTD cell lines 
used for the microarray analysis, and in addition in cell strains TTD11PV (XPD 
R112H), TTD2GL (XPD R112H), TTD1BR (TTD-A) and TTD1BI (XPD frameshift 
730). Two individuals with wt XPD were used as negative and positive controls for 
GSTT1.
Fig. 2 - Recovery of RNA synthesis after UV-C-irradiation
Cells were UV-irradiated with the indicated doses and RNA synthesis measured by 
incorporation of 3H uridine 16 h later. 
Fig. 3 - Biological processes specifically induced (A.) or repressed (B.) after 
UV-C-irradiation.
The software application EASE was used to discover enriched biological themes by 
identifying gene categories containing an over-representatively high number of 
differentially expressed genes among the gene lists obtained from the LIMMA 
analysis. Black bar; normal cell strains. Grey bar; XP-D strains. White bar; TTD 
strains.
Fig. 4 - Analysis of UV treated compared to untreated cells. 
Venn diagrams of genes identified to be differentially expressed after UV treatment: 
A. up-regulated after UV. B. down-regulated after UV.   
Fig. S1 - Gene expression data repeated by qPCR.
To confirm the data obtained from the microarray analysis, RNA was isolated from a 
separate UV-irradiation experiment and gene expression was assayed using qPCR. 
Expression levels of the TATA binding protein (TBP) were used to normalise the 
expression data obtained for the different genes of interests. Expression levels of 
24
eight genes were assayed. The same cell strains as used in the microarray were 
assayed. 1BR, dark blue. 48BR, turquoise. 245BR, light blue. XP1DU, organge. 
XP30BR, dark yellow. XP1BR, light yellow. TTD7BR, dark green. TTD1BEL, medium 
green. TTD9VI, light green. A log2(fold change) of x means that the gene was 
upregulated 2x-fold.
Fig. S2 - Gene expression of HOXC4  repeated by qPCR. 
To confirm the data obtained from the microarray analysis, RNA was isolated from a 
separate UV-irradiation experiment and gene expression was assayed using qPCR. 
Expression levels of the TATA binding protein (TBP) were used to normalise the 
expression data obtained for HoxC4. Expression levels were plotted as the log2 of 
the fold change.
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